EnVVeno Capital Surpluse vs Current Deferred Revenue Analysis

NVNO Stock

USD 4.99 0.04 0.81%

EnVVeno Medical financial indicator trend analysis is much more than just examining enVVeno Medical Corp latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether enVVeno Medical Corp is a good investment. Please check the relationship between EnVVeno Medical Capital Surpluse and its Current Deferred Revenue accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in enVVeno Medical Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

Capital Surpluse vs Current Deferred Revenue

Capital Surpluse vs Current Deferred Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of enVVeno Medical Corp Capital Surpluse account and Current Deferred Revenue. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between EnVVeno Medical's Capital Surpluse and Current Deferred Revenue is 0.58. Overlapping area represents the amount of variation of Capital Surpluse that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of enVVeno Medical Corp, assuming nothing else is changed. The correlation between historical values of EnVVeno Medical's Capital Surpluse and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Surpluse of enVVeno Medical Corp are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Capital Surpluse i.e., EnVVeno Medical's Capital Surpluse and Current Deferred Revenue go up and down completely randomly.

Correlation Coefficient

0.58

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Capital Surpluse

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

Most indicators from EnVVeno Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into enVVeno Medical Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in enVVeno Medical Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

As of the 19th of May 2024, Enterprise Value is likely to grow to about 64.1 M, while Selling General Administrative is likely to drop about 9.4 M.

	2021	2022	2023	2024 (projected)
Reconciled Depreciation	452.9K	525K	542K	404.4K
Research Development	5.7M	9.9M	13.6M	14.3M

Reconciled Depreciation Research Development

EnVVeno Medical fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Net Receivables	Net Tangible Assets	Other Assets
Total Assets		0.12	-0.5	-0.57	0.99	0.87	-0.31	-0.59	-0.9	-0.33	0.59	0.69	-0.3	1.0	0.96	-0.22	0.85	0.95	-0.47	1.0	-0.56	-0.56	-0.34	-0.6	0.98	-0.68
Short Long Term Debt Total	0.12		0.7	0.68	0.02	-0.03	0.09	-0.12	0.12	-0.13	0.16	0.28	0.59	0.11	0.08	0.46	0.15	-0.06	0.67	0.11	0.7	0.23	-0.19	0.16	-0.01	0.43
Other Current Liab	-0.5	0.7		0.97	-0.58	-0.61	0.05	0.45	0.51	0.2	-0.41	-0.26	0.79	-0.5	-0.44	0.59	-0.29	-0.54	0.91	-0.5	0.95	0.57	-0.2	0.4	-0.59	0.73
Total Current Liabilities	-0.57	0.68	0.97		-0.65	-0.64	0.22	0.36	0.63	0.27	-0.32	-0.25	0.79	-0.57	-0.56	0.61	-0.42	-0.64	0.94	-0.57	0.96	0.62	-0.15	0.44	-0.66	0.77
Total Stockholder Equity	0.99	0.02	-0.58	-0.65		0.88	-0.33	-0.59	-0.91	-0.33	0.58	0.65	-0.39	0.99	0.96	-0.32	0.85	0.96	-0.56	0.99	-0.64	-0.62	-0.3	-0.61	0.99	-0.73
Property Plant And Equipment Net	0.87	-0.03	-0.61	-0.64	0.88		-0.19	-0.67	-0.8	-0.13	0.67	0.79	-0.34	0.87	0.8	-0.34	0.65	0.83	-0.56	0.87	-0.66	-0.68	-0.22	-0.68	0.91	-0.77
Current Deferred Revenue	-0.31	0.09	0.05	0.22	-0.33	-0.19		-0.53	0.62	-0.02	0.53	-0.02	0.15	-0.32	-0.55	0.29	-0.59	-0.53	0.28	-0.32	0.24	0.38	0.2	0.39	-0.35	0.42
Net Debt	-0.59	-0.12	0.45	0.36	-0.59	-0.67	-0.53		0.29	0.13	-1.0	-0.55	0.2	-0.59	-0.35	0.14	-0.22	-0.39	0.3	-0.59	0.38	0.37	0.18	0.34	-0.59	0.39
Retained Earnings	-0.9	0.12	0.51	0.63	-0.91	-0.8	0.62	0.29		0.09	-0.27	-0.57	0.31	-0.9	-0.95	0.34	-0.84	-0.99	0.56	-0.9	0.67	0.65	0.38	0.77	-0.93	0.83
Accounts Payable	-0.33	-0.13	0.2	0.27	-0.33	-0.13	-0.02	0.13	0.09		-0.14	0.0	0.46	-0.33	-0.34	0.04	-0.44	-0.18	0.18	-0.33	0.01	-0.06	-0.31	-0.5	-0.21	-0.23
Cash	0.59	0.16	-0.41	-0.32	0.58	0.67	0.53	-1.0	-0.27	-0.14		0.56	-0.17	0.59	0.34	-0.12	0.22	0.38	-0.26	0.58	-0.34	-0.35	-0.19	-0.32	0.58	-0.36
Non Current Assets Total	0.69	0.28	-0.26	-0.25	0.65	0.79	-0.02	-0.55	-0.57	0.0	0.56		0.18	0.68	0.62	0.22	0.37	0.61	-0.05	0.68	-0.31	-0.21	-0.08	-0.58	0.68	-0.44
Non Currrent Assets Other	-0.3	0.59	0.79	0.79	-0.39	-0.34	0.15	0.2	0.31	0.46	-0.17	0.18		-0.31	-0.29	0.82	-0.41	-0.34	0.89	-0.31	0.65	0.58	-0.28	-0.03	-0.35	0.45
Cash And Short Term Investments	1.0	0.11	-0.5	-0.57	0.99	0.87	-0.32	-0.59	-0.9	-0.33	0.59	0.68	-0.31		0.96	-0.23	0.86	0.95	-0.48	1.0	-0.56	-0.56	-0.35	-0.6	0.98	-0.68
Common Stock Shares Outstanding	0.96	0.08	-0.44	-0.56	0.96	0.8	-0.55	-0.35	-0.95	-0.34	0.34	0.62	-0.29	0.96		-0.21	0.91	0.97	-0.46	0.96	-0.54	-0.52	-0.32	-0.58	0.94	-0.66
Non Current Liabilities Total	-0.22	0.46	0.59	0.61	-0.32	-0.34	0.29	0.14	0.34	0.04	-0.12	0.22	0.82	-0.23	-0.21		-0.37	-0.33	0.85	-0.23	0.57	0.85	-0.11	0.25	-0.33	0.61
Other Current Assets	0.85	0.15	-0.29	-0.42	0.85	0.65	-0.59	-0.22	-0.84	-0.44	0.22	0.37	-0.41	0.86	0.91	-0.37		0.87	-0.43	0.86	-0.34	-0.54	-0.33	-0.36	0.81	-0.51
Other Stockholder Equity	0.95	-0.06	-0.54	-0.64	0.96	0.83	-0.53	-0.39	-0.99	-0.18	0.38	0.61	-0.34	0.95	0.97	-0.33	0.87		-0.57	0.95	-0.66	-0.64	-0.36	-0.72	0.97	-0.8
Total Liab	-0.47	0.67	0.91	0.94	-0.56	-0.56	0.28	0.3	0.56	0.18	-0.26	-0.05	0.89	-0.48	-0.46	0.85	-0.43	-0.57		-0.48	0.89	0.79	-0.15	0.41	-0.58	0.78
Total Current Assets	1.0	0.11	-0.5	-0.57	0.99	0.87	-0.32	-0.59	-0.9	-0.33	0.58	0.68	-0.31	1.0	0.96	-0.23	0.86	0.95	-0.48		-0.56	-0.56	-0.35	-0.6	0.98	-0.68
Short Term Debt	-0.56	0.7	0.95	0.96	-0.64	-0.66	0.24	0.38	0.67	0.01	-0.34	-0.31	0.65	-0.56	-0.54	0.57	-0.34	-0.66	0.89	-0.56		0.65	-0.01	0.64	-0.68	0.87
Intangible Assets	-0.56	0.23	0.57	0.62	-0.62	-0.68	0.38	0.37	0.65	-0.06	-0.35	-0.21	0.58	-0.56	-0.52	0.85	-0.54	-0.64	0.79	-0.56	0.65		0.1	0.63	-0.66	0.84
Common Stock	-0.34	-0.19	-0.2	-0.15	-0.3	-0.22	0.2	0.18	0.38	-0.31	-0.19	-0.08	-0.28	-0.35	-0.32	-0.11	-0.33	-0.36	-0.15	-0.35	-0.01	0.1		0.42	-0.33	0.23
Net Receivables	-0.6	0.16	0.4	0.44	-0.61	-0.68	0.39	0.34	0.77	-0.5	-0.32	-0.58	-0.03	-0.6	-0.58	0.25	-0.36	-0.72	0.41	-0.6	0.64	0.63	0.42		-0.71	0.88
Net Tangible Assets	0.98	-0.01	-0.59	-0.66	0.99	0.91	-0.35	-0.59	-0.93	-0.21	0.58	0.68	-0.35	0.98	0.94	-0.33	0.81	0.97	-0.58	0.98	-0.68	-0.66	-0.33	-0.71		-0.8
Other Assets	-0.68	0.43	0.73	0.77	-0.73	-0.77	0.42	0.39	0.83	-0.23	-0.36	-0.44	0.45	-0.68	-0.66	0.61	-0.51	-0.8	0.78	-0.68	0.87	0.84	0.23	0.88	-0.8

Click cells to compare fundamentals

EnVVeno Medical Account Relationship Matchups

EnVVeno Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	3.4M	10.5M	57.7M	41.7M	48.6M	51.1M
Other Current Liab	333.4K	1.1M	60.1K	568K	1.0M	901.0K
Total Current Liabilities	1.9M	3.2M	1.6M	1.5M	1.4M	2.3M
Total Stockholder Equity	989.9K	7.1M	54.4M	38.7M	46.2M	48.5M
Property Plant And Equipment Net	1.2M	938.9K	2.6M	2.2M	1.7M	1.1M
Net Debt	(450.6K)	(8.5M)	(52.7M)	(2.8M)	(2.2M)	(2.3M)
Retained Earnings	(56.2M)	(65.3M)	(81.9M)	(106.5M)	(130.0M)	(123.5M)
Accounts Payable	1.2M	1.4M	560.1K	648K	427K	705.4K
Cash	1.3M	9.3M	54.7M	4.6M	3.6M	3.4M
Non Current Assets Total	2.0M	968.8K	2.7M	2.2M	1.7M	1.8M
Cash And Short Term Investments	1.3M	9.3M	54.7M	39.0M	46.4M	48.7M
Common Stock Shares Outstanding	630.4K	1.3M	8.7M	11.2M	12.3M	12.9M
Liabilities And Stockholders Equity	3.4M	10.5M	57.7M	41.7M	48.6M	51.1M
Non Current Liabilities Total	567.9K	253.7K	1.7M	1.4M	1.1M	1.5M
Other Current Assets	116.6K	234.5K	312.4K	392K	511K	536.6K
Other Stockholder Equity	57.2M	72.4M	136.3M	145.2M	176.2M	185.0M
Total Liab	2.4M	3.4M	3.3M	2.9M	2.4M	3.7M
Total Current Assets	1.4M	9.6M	55.0M	39.4M	46.9M	49.3M
Short Term Debt	288.7K	626.9K	291.1K	314K	338K	619.4K
Common Stock	117.0	179.0	25.0	95.0	85.5	82.17
Net Tangible Assets	989.9K	7.1M	54.4M	38.7M	44.5M	46.8M
Net Invested Capital	989.9K	7.4M	54.4M	38.7M	46.2M	48.5M
Net Working Capital	(452.4K)	6.4M	53.5M	37.9M	45.6M	47.8M
Property Plant Equipment	1.2M	938.9K	2.6M	521K	599.2K	968.9K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether enVVeno Medical Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of EnVVeno Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Envveno Medical Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Envveno Medical Corp Stock:

How To Invest In EnVVeno

Details

Is EnVVeno Stock a good investment?

Details

What is EnVVeno Medical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in enVVeno Medical Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Complementary Tools for EnVVeno Stock analysis

When running EnVVeno Medical's price analysis, check to measure EnVVeno Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EnVVeno Medical is operating at the current time. Most of EnVVeno Medical's value examination focuses on studying past and present price action to predict the probability of EnVVeno Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EnVVeno Medical's price. Additionally, you may evaluate how the addition of EnVVeno Medical to your portfolios can decrease your overall portfolio volatility.

	Content Syndication Quickly integrate customizable finance content to your own investment portal
	ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
	Stocks Directory Find actively traded stocks across global markets
	Commodity Directory Find actively traded commodities issued by global exchanges
	USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA
	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios
	Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk

Is EnVVeno Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EnVVeno Medical. If investors know EnVVeno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EnVVeno Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.65)

Return On Assets

(0.37)

Return On Equity

(0.58)

The market value of enVVeno Medical Corp is measured differently than its book value, which is the value of EnVVeno that is recorded on the company's balance sheet. Investors also form their own opinion of EnVVeno Medical's value that differs from its market value or its book value, called intrinsic value, which is EnVVeno Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EnVVeno Medical's market value can be influenced by many factors that don't directly affect EnVVeno Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between EnVVeno Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if EnVVeno Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EnVVeno Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

EnVVeno Capital Surpluse vs Current Deferred Revenue Analysis

Capital Surpluse vs Current Deferred Revenue

Capital Surpluse vs Current Deferred Revenue Correlation Analysis

Correlation Coefficient

Capital Surpluse

Current Deferred Revenue

EnVVeno Medical fundamental ratios Correlations

EnVVeno Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

EnVVeno Medical fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for EnVVeno Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Cash And Short Term Investments
Total Stockholder Equity	+ 0.99	Total Assets
Cash And Short Term Investments	+ 0.99	Total Stockholder Equity
Total Current Assets	+ 0.99	Total Stockholder Equity

Cash	- 1.0	Net Debt
Other Stockholder Equity	- 0.99	Retained Earnings
Common Stock Shares Outstanding	- 0.95	Retained Earnings
Net Tangible Assets	- 0.93	Retained Earnings
Retained Earnings	- 0.91	Total Stockholder Equity
Total Current Assets	- 0.9	Retained Earnings